Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/14/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Harold Jacob?

Harold Jacob

Director of Advanced Gastrointestinal Endoscopy

Hadassah Hospital

HQ Phone:  (212) 355-7900

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Hadassah Hospital

40 Wall Street

New York City, New York,10005

United States

Company Description

Hadassah is the largest Jewish women's organization in the United States. With 330,000 members, associates and supporters across the country, Hadassah brings Jewish women together to effect change and advocate on critical issues such as medical care and resear...more

Web References(45 Total References)


Scientific Advisory Board On Oral Drug Delivery - Oramed

www.oramed.com [cached]

Harold Jacob, MD
Dr. Jacob currently serves as Chief Medical Officer of NanoVibronix. Previously, Dr. Jacob was Director of Medical Affairs at Given Imaging and was instrumental in the development and launch of the Given Imaging PillcamTM. Dr. Jacob has patented and licensed a number of medical devices. He is Board Certified in Internal Medicine and Gastroenterology and is Director of Advanced Gastrointestinal Endoscopy at Hadassah Medical Center, Jerusalem.


Board of Directors - Oramed Pharmaceuticals

www.oramed.com [cached]

Harold Jacob, M.D.
Director Dr. Jacob has been an Oramed director since 2008, having previously served on the company's Scientific Advisory Board. He has a strong background in medical sciences as well as biotechnology and medical devices. Dr. Jacob is president of Medical Instrument Development Inc., a company which provides a range of support and consulting services to start-up and early stage companies. Dr. Jacob practiced clinical gastroenterology in New York and served as Chief of Gastroenterology at St. John's Episcopal Hospital and South Nassau Communities Hospital, and was a Clinical Assistant Professor of Medicine at SUNY. He is currently the Director of Gastrointestinal Endoscopy at Hadassah University Hospital.


www.hadassahmagazine.org

One of the inventors of this breakthrough medical device is Dr. Harold Jacob, an attending physician at Hadassah and the founding president of NanoVibronix, the company that developed PainShield.
The article mentions PainShield in connection with treating chronic wounds. Although this is a very promising application, PainShield is only approved for use in the USA for treating pain. Our company, KevMed LLC, distributes this device focusing on treating the 8-15 American million patients with chronic pelvic, abdominal, bladder and related pain. Working with Dr. Jacob and NanoVibronix, we performed clinical studies and pioneered the use of PainShield for this kind of pain.


www.sec.gov

Harold Jacob
Dr. Harold Jacob was appointed a director in July 2008. Since 1998, Dr. Jacob has served as the president of Medical Instrument Development Inc., a company which provides a range of support and consulting services to start-up and early stage companies as well as patenting its own proprietary medical devices. Since 2011, Dr. Jacob has also served as an attending physician at Hadassah University Medical Center, where he has served as the director of the gastrointestinal endoscopy unit since September 2013. Dr. Jacob has advised a spectrum of companies in the past and he served as a consultant and then as the Director of Medical Affairs at Given Imaging Ltd., from 1997 to 2003, a company that developed the first swallowable wireless pill camera for inspection of the intestine. He has licensed patents to a number of companies including Kimberly-Clark Corporation. Since 2014, Dr. Jacob has served as the Chief Medical Officer and a director of NanoVibronix, Inc., a medical device company using surface acoustics to prevent catheter acquired infection as well as other applications, where he served as Chief Executive Officer from 2004 to 2014. He practiced clinical gastroenterology in New York and served as Chief of Gastroenterology at St. John's Episcopal Hospital and South Nassau Communities Hospital from 1986 to 1995, and was a Clinical Assistant Professor of Medicine at SUNY from 1983 to 1990. Dr. Jacob founded and served as Editor in Chief of Endoscopy Review and has authored numerous publications in the field of gastroenterology. We believe that Dr. Jacob's qualifications to serve on our Board include his years of experience in the biomed industry, his experience serving in management roles of various companies, as well as his knowledge and familiarity with gastroenterology. The Board has determined that Michael Berelowitz, Harold Jacob, Gerald Ostrov and Leonard Sank, are independent as defined under the rules promulgated by NASDAQ. The members of our Audit Committee are Leonard Sank, Harold Jacob and Gerald Ostrov.


www.sec.gov

Harold Jacob
Dr. Harold Jacob was appointed a director in July 2008. Since 1998, Dr. Jacob has served as the president of Medical Instrument Development Inc., a company which provides a range of support and consulting services to start-up and early stage companies as well as patenting its own proprietary medical devices. Since 2011, Dr. Jacob has also served as an attending physician at Hadassah University Medical Center, where he has served as the director of the gastrointestinal endoscopy unit since September 2013. Dr. Jacob has advised a spectrum of companies in the past and he served as a consultant and then as the Director of Medical Affairs at Given Imaging Ltd., from 1997 to 2003, a company that developed the first swallowable wireless pill camera for inspection of the intestine. He has licensed patents to a number of companies including Kimberly-Clark Corporation. Since 2014, Dr. Jacob has served as the Chief Medical Officer and a director of NanoVibronix, Inc., a medical device company using surface acoustics to prevent catheter acquired infection as well as other applications, where he served as Chief Executive Officer from 2004 to 2014. He practiced clinical gastroenterology in New York and served as Chief of Gastroenterology at St. John's Episcopal Hospital and South Nassau Communities Hospital from 1986 to 1995, and was a Clinical Assistant Professor of Medicine at SUNY from 1983 to 1990. Dr. Jacob founded and served as Editor in Chief of Endoscopy Review and has authored numerous publications in the field of gastroenterology. We believe that Dr. Jacob's qualifications to serve on our Board include his years of experience in the biomed industry, his experience serving in management roles of various companies, as well as his knowledge and familiarity with gastroenterology. The Board has determined that Michael Berelowitz, Harold Jacob, Gerald Ostrov and Leonard Sank, are independent as defined under the rules promulgated by NASDAQ. The members of our Audit Committee are Leonard Sank, Harold Jacob and Gerald Ostrov. Harold Jacob, a director, failed to timely file a Form 4 reporting his April 14, 2014 acquisition of 700 shares of our common stock. Mr. Jacob filed a Form 4 reporting this transaction on April 18, 2014. ● Harold Jacob also failed to timely file a Form 4 reporting a sale of an aggregate of 834 shares of our common stock on December 30, 2013. Mr. Jacob filed a Form 4 reporting this transaction on January 29, 2014.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory